Francesc Bosch

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Leukemia & lymphoma

Leukemia

Clinical cancer research : an official journal of the American Association for Cancer Research

Vall d'Hebron Institute of Oncology

Universitat de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vall d'Hebron Institute of Oncology

Spain

Director :: Experimental Hematology

Universitat Autònoma de Barcelona

Spain

Associated Professor :: Medicina

Hospital Vall d'Hebron

Spain

Head of Department :: Hematology

Education History

Universitat de Barcelona - Jul 28 1998

Spain

PHD

Publications

L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, Pamela Acha, Onyee Chan, Víctor Navarro, Yasuo Kubota, Felicitas Isabel Schulz, Manja Meggendorfer, Robert Briski, Najla Al-Ali, Blanca Xicoy, Felix Lopez, Francesc Bosch, Teresa González, Lea Naomi Eder, Andrés Jerez, Yu-Hung Hung Wang, Alessia Campagna, Valeria Santini, Teresa Bernal Del Castillo, Esperanza Such, Hwei-Fang Tien, Nicolás Díaz Varela, Uwe Platzbecker, Detlef Thomas Haase, Maria Diez Campelo, Matteo Giovanni Della Porta, Guillermo Garcia-Manero, Daniel Howard Wiseman, Ulrich Germing, Jaroslaw P Maciejewski, Rami S Komrokji, Francisco Solé, Torsten Haferlach, David Valcárcel
Influence of TP53 Gene Mutations and its Allelic Status in Myelodysplastic Syndromes with Isolated 5q Deletion. Blood (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Chan Yoon Y Cheah, Connie Y Ma, Huang Huang, Antonia Kwan, Michael C Wei, Shen Yin, Nancy L Bartlett
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Pau Abrisqueta, Daniel Medina, Guillermo Villacampa, JunYan Lu, Miguel Alcoceba, Julia Carabia, Joan Boix, Barbara Tazón-Vega, Gloria Iacoboni, Sabela Bobillo, Ana Marin-Niebla, Marcos González-Díaz, Thorsten Zenz, Marta Crespo, Francesc Bosch
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression. Blood advances 6 (21) (2022)
L Elizabeth Elizabeth Budde, Sarit E Assouline, Laurie Helen Sehn, Stephen J Schuster, Sung-Soo Yoon, Dok Hyun Yoon, Matthew J Matasar, Francesc Bosch, Won Seog Kim, Loretta J Nastoupil, Ian W Flinn, Mazyar Shadman, Catherine S Diefenbach, Carol O'Hear, Huang Huang, Antonia Kwan, Chi-Chung Li, Emily C Piccione, Michael C Wei, Shen Yin, Nancy L Bartlett
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (5) (2021)
Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles, Núria Profitós-Pelejà, Juliana Carvalho Santos, Marc Armengol, Miranda Fernandez-Serrano, Alícia Sedó Mor, Joan J Bech-Serra, Pedro Blecua, Eva Musulen, Carolina de la Torre, Hari Miskin, Manel Esteller, Francesc Bosch, Pablo Menéndez, Emmanuel Normant, Gael Roué
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Isabel Jiménez, Bárbara Tazón-Vega, Pau Abrisqueta, Juan C Nieto, Sabela Bobillo, Carles Palacio-García, Júlia Carabia, Rafael Valdés-Mas, Magdalena Munuera, Lluís Puigdefàbregas, Genís Parra, Anna Esteve-Codina, Clara Franco-Jarava, Gloria Iacoboni, María José Terol, José Antonio García-Marco, Marta Crespo, Francesc Bosch
Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia. Biomarker research 9 (1) (2021)
Cecilia Carpio, Gloria Iacoboni, Guillermo Villacampa, Eva Catalá, Sabela Bobillo, Ana Pérez, Moraima Jiménez, Laura Segura, Mireia Olivé, Anna Farriols, Pau Abrisqueta, David Valcarcel, María Josep Carreras, Francesc Bosch, Pere Barba
Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center. Leukemia & lymphoma 62 (9) (2021)
José Luis Piñana, Lourdes Vázquez, Rodrigo Martino Bofarull, Rafael de la Cámara, Anna Sureda, Rebeca Rodríguez-Veiga, Ana Garrido, Marta Pratcorona, Josep-María Ribera, Anna Torrent, Maria-Victoria Mateos-Manteca, Javier de la Rubia, María Del Mar Tormo Díaz, María Díez-Campelo, Valentín García-Gutiérrez, Alberto Álvarez-Larrán, Juan-Manuel Sancho, Alejandro MartínGarcía-Sancho, Lucrecia Yañez, José Antonio Pérez Simón, Pere Barba, Pau Abrisqueta, Iván Álvarez-Twose, Santiago Bonanad, Ramón Lecumberri, Isabel Ruiz-Camps, David Navarro, José-Ángel Hernández-Rivas, Ángel Cedillo, Ramón García-Sanz, Francesc Bosch
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. Leukemia & lymphoma (2021)
Francesc Bosch, Blanca Navarro, Marta Crespo, Miguel Alcoceba, Julio Bravo Sánchez, Barbara Tazón, Alicia Serrano, María García Álvarez, Lydia González Serrano, Pablo Alonso-Torres, Miguel Villanueva, Cristina Loriente, Pau Abrisqueta, Manel Peiró, Jose Antonio Garcia-Marco, Marcos González-Díaz, María José Terol
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative. Annals of hematology 100 (3) (2021)
Juan Camilo Nieto, Elisa Roldán, Isabel Jiménez, Laura Fox, Júlia Carabia, Guillermo Ortí, Lluís Puigdefàbregas, Laura Gallur, Gloria Iacoboni, Priyanka Raheja, Ana Pérez, Sabela Bobillo, Olga Salamero, Carlos Palacio, David Valcárcel, Marta Crespo, Francesc Bosch, Pere Barba
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy. Leukemia 34 (12) (2020)
Leo I Gordon, Jason B Kaplan, Rakesh Popat, Howard A Burris, Silvia Ferrari, Sumit Madan, Manish R Patel, Giuseppe Gritti, Dima El-Sharkawi, Ian Chau, John A Radford, Jaime Pérez de Oteyza, Pier Luigi Zinzani, Swaminathan Iyer, William Townsend, Reem Karmali, Harry Miao, Igor Proscurshim, Shining Wang, Yujun Wu, Kate Stumpo, Yaping Shou, Cecilia Carpio, Francesc Bosch
Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Olga Salamero, Pau Montesinos, Christophe Willekens, José Antonio Pérez-Simón, Arnaud Pigneux, Christian Récher, Rakesh Popat, Cecilia Carpio, César Molinero, Cristina Mascaró, Joaquim Vila, M Isabel Arévalo, Tamara Maes, Carlos Buesa, Francesc Bosch, Tim C P Somervaille
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Maria Laura Fox, García-Cadenas Irene, Ariadna Martínez Pérez, Guillermo Villacampa, José Luis Piñana, Guillermo Ortí, Juan Montoro Gómez, Elisa Roldán, Anna Bosch Vilaseca, Rodrigo Martino Bofarull, Olga Salamero, Silvana Saavedra, Juan Carlos Carlos Hernández-Boluda, Albert Esquirol, Marta Pratcorona, Jaime Sanz Caballer, Carlos Solano, Francesc Bosch, Pere Barba, David Valcarcel
Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis. Leukemia & lymphoma 61 (8) (2020)
Francesc Bosch, Riccardo Dalla-Favera
Chronic lymphocytic leukaemia: from genetics to treatment. Nature reviews. Clinical oncology 16 (11) (2019)
Francesc Bosch, Guy Cantin, Agostino Cortelezzi, Wolfgang Knauf, Mourad Tiab, Mehmet Turgut, Andrey Zaritskey, Jean-Louis Merot, Eugen Tausch, Kerstin Trunzer, Susan Robson, Ekaterina Gresko, Sebastian Böttcher, Robin Foà, Stephan Stilgenbauer, Véronique Leblond
Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study. Leukemia 34 (2) (2019)
Francesc Bosch, Pau Abrisqueta
Ibrutinib in CLL: 2 sides of the same coin. Blood 126 (19) (2016)

Francesc Bosch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesc Bosch